Neuralace is a medical technology company specializing in innovative non-invasive solutions for the treatment of chronic peripheral neuropathic pain that offers Axon Therapy, a non-opioid treatment for postoperative pain, according to a May 25 news release.
“Axon Therapy is an excellent complement to conventional, implantable neuromodulation, bringing the benefits of neurostimulation to many more patients,” Dr. Staats said. “I look forward to working alongside [fellow board members] to support the market entry of this much-needed non-invasive approach.”
In his role, Dr. Staats will provide insight and strategy for Neuralace and its treatments.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
